Trial intelligence / Profile preview

N-of-1 Crossover Trials of Antihypertensive Therapy in Adolescents

NCT02412761Completed

Sponsor
UTHealth Houston
Start
Jun 2013
Primary completion
Jul 2016
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of lisinopril, amlodipine and hydrochlorothiazide in essential hypertension, sponsored by UTHealth Houston. Started Jun 2013; status: completed.

02

Drugs

lisinoprilamlodipinehydrochlorothiazide
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT02412761.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02412761.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call